Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Algernon’s Ifenprodil lowers interleukin 6 in Phase IIb/III Covid-19 trial

pharmaceutical-technologyMay 13, 2021

Tag: Algernon , IL-6 , COVID-19

PharmaSources Customer Service